INB-200: FULLY ENROLLED PHASE 1 STUDY OF GENE-MODIFIED AUTOLOGOUS GAMMA-DELTA (yδ) T CELLS IN NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM) PATIENTS RECEIVING MAINTENANCE TEMOZOLOMIDE (TMZ)

Authors
Category Primary study
JournalNeuro-Oncology
Year 2024
This article has no abstract
Epistemonikos ID: b5a95b64b31d6a7a8774fc287a3635ee84ee5b64
First added on: Feb 19, 2025